Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
An observational disease and clinical outcomes registry of patients with acid lipase (LAL) deficiency	Alexion Pharma International Sàrl.	Ongoing	Kanuma	4	ALX-LALD-5	King Faisal Specialist Hospital and Research Center (Riyadh)
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Arena film-coated tablets (150 mg irbesartan) Produced by Jamjoom/ KSA versus Aprovel® film-coated tablets (150 mg irbesartan) Produced by Sanofi-aventis / Germany, in healthy subjects under fasting condition.	SFDA	Ongoing	Arena	BE	Aug-17	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Capocard tablets (25 mg captopril) Produced by Dar AlDawa / Jordan versus Capoten® tablets (25 mg captopril) Produced by SPIMACO / KSA, in healthy subjects under fasting condition.	SFDA	Ongoing	Capocard	BE	Jul-17	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Biscor film-coated tablets (10 mg bisoprolol fumarate) Produced by Pharma International / Jordan versus Concor® film-coated tablets (10 mg bisoprolol fumarate) Produced by Merck / Germany, in healthy subjects under fasting condition.	SFDA	Ongoing	Biscor	BE	Sep-17	Saudi Ajal
Randomized, three-way, three-period, single oral dose, open-label, crossover, bioequivalence study to compare Lipomax tablets (20 mg atorvastatin) Produced by SAJA / KSA, versus Lipitor® tablets (20 mg atorvastatin) Produced by Pfizer / Ireland, in healthy subjects under fasting conditions.	SFDA	Ongoing	Lipomax	BE	Nov-17	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Pedovex film-coated tablets (75 mg clopidogrel) Produced by Tabuk / KSA versus Plavix® film-coated tablets (75 mg clopidogrel) Produced by Sanofi-aventis / KSA, in healthy subjects under fasting condition.	SFDA	Ongoing	Pedovex	BE	Oct-17	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glymide tablets (5 mg glibenclamide) Produced by Julphar / UAE versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition.	SFDA	Ongoing	Glymide	BE	13-2017	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Amlophar Capsules (5 mg amlodipine) Produced by Julphar / UAE versus Amlor® Capsules (5 mg amlodipine) Produced by Pfizer / KSA, in healthy subjects under fasting condition.	SFDA	Ongoing	Amlophar	BE	Dec-17	Saudi Ajal
Randomized, three-way, three-period, single oral dose, open-label, crossover, bioequivalence study to compare Torvacol tablets (20 mg atorvastatin) Produced by JPM / Jordan, versus Lipitor® tablets (20 mg atorvastatin) Produced by Pfizer / Irland in healthy subjects under fasting conditions.	SFDA	Ongoing	Torvacol	BE	15-2017	Saudi Ajal
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Narapril tablets (20 mg enalapril) Produced by Julphar / UAE versus Renitec® tablets (20 mg enalapril) Produced by Merck Sharp & Dohme / UK, in healthy subjects under fasting condition.	SFDA	Ongoing	Narapril	BE	14-2017	Saudi Ajal